Search

Displaying results 6231 - 6240 of 10000 in total
  1. Drug

    Rumex salicifolius var. mexicanus pollen

    go.drugbank.com/drugs/DB10902
    Approved

    Rumex salicifolius var. mexicanus pollen is mainly used in allergenic testing.

  2. Drug

    Salix lucida ssp. lasiandra pollen

    go.drugbank.com/drugs/DB10916
    Approved

    Salix lucida ssp. lasiandra pollen is mainly used in allergenic testing.

  3. Drug

    Sorghum bicolor subsp. bicolor pollen

    go.drugbank.com/drugs/DB10965
    Approved

    Sorghum bicolor subsp. bicolor pollen is mainly used in allergenic testing.

  4. Drug

    Sorghum bicolor subsp. drummondii pollen

    go.drugbank.com/drugs/DB10966
    Approved

    Sorghum bicolor subsp. drummondii pollen is mainly used in allergenic testing.

  5. Drug

    Tanaproget

    go.drugbank.com/drugs/DB04787
    Experimental

    Tanaproget (NSP-989) is an investigational non-steroidal progestin. … An analog of tanaproget, 4-fluoropropyltanaproget (18F), has been developed as a radiotracer for imaging of the PR in positron emission tomography.

  6. Drug

    Pipecuronium

    go.drugbank.com/drugs/DB01338
    ApprovedInvestigationalWithdrawn

    Pipecuronium is a piperazinyl androstane derivative which is a non-depolarizing neuromuscular blocking agent.

  7. Drug

    Lexaptepid pegol

    go.drugbank.com/drugs/DB12578
    Investigational

    Lexaptepid pegol has been used in trials studying the treatment of Anemia, Inflammation, Chronic Diseases, End Stage Renal Disease, and Anemia of Chronic Disease.

  8. Drug

    Meticrane

    go.drugbank.com/drugs/DB13284
    Approved

    It has been marketed in Japan under the trade name Arresten and is used to lower blood pressure [L5647].

  9. Drug

    D-3082-L

    go.drugbank.com/drugs/DB17440
    Experimental

    D-3082-L is one of the components of the human papilloma virus (HPV) type 16 E6/E7 synthetic long peptide (SLP) vaccine ISA101b.

    Synonyms: Human Papilloma Virus (HPV) Type 16 E6/e7 Synthetic Long Peptide (SLP) Vaccine Component D-3082-L
  10. Drug

    Palazestrant

    go.drugbank.com/drugs/DB18971
    Investigational

    Palazestrant is under investigation in clinical trial NCT06016738 (OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer).